Persistent and symptomatic post-transplant hyperparathyroidism: A dramatic response to cinacalcet [11]

Nephrology Dialysis Transplantation

Volumn 21, Issue 6, 2006, Pages 1736-

  Leonard, Niall ^a   Brown, John H ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CINACALCET; CYCLOSPORIN; OPIATE; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; BONE PAIN; CALCIUM BLOOD LEVEL; CASE REPORT; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HAND RADIOGRAPHY; HUMAN; HYPERPARATHYROIDISM; HYPOCALCEMIA; KIDNEY TRANSPLANTATION; LETTER; MYALGIA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

AGED; BONE DISEASES; FEMALE; HUMANS; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; NAPHTHALENES; TREATMENT OUTCOME;

EID: 33744808295     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk018     Document Type: Letter

References (2)

1. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311-1314
2. Serra AL, Schwarz AA, Wick FH, Marti H-P, Wüthrich RP. Successful treatment of hypercalcaemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315-1319